Foods for Great Oral Health: 5 to Eat and 5 to Avoid

  • During the COVID-19 pandemic, many people are concerned about maintaining good oral health and reducing their need for additional dental appointments.
  • Being mindful of which foods you eat, and which ones you avoid, can help improve your oral health.
  • Experts say to avoid sugary, processed, acidic, and high carbohydrate foods without significant nutritional value.
  • Instead, focus on foods that are high in fiber and contain important nutrients your mouth needs, like calcium, phosphorus, and magnesium.

Pandemic life has many of us wondering how missing out on normal dental appointments will change the likelihood of cavities, gum bleeding, oral thrush, or other oral health problems.

However, if you want to know how to optimize your oral health during the COVID-19 pandemic, start with your diet.

Loading up on comfort food is, unfortunately, not the best option for your teeth and gums.

To build strong teeth, focus on foods that are low in carbohydrates and sugars, high in fiber, and contain important nutrients your mouth needs, like calcium, phosphorus, and magnesium. Avoid sugary, processed, acidic, and high carbohydrate foods without significant nutritional value.

Let’s take a look at five foods that’ll actively promote oral health and five that’ll increase your likelihood of cavities, bleeding gums, and sensitive teeth.

Foods to eat

1. Cacao nibs

Polyphenols in cocoa successfully kill cavity-causing bacteria and create a barrier between teeth and plaque. Getty Images

Chocolate is certainly a comfort food, but without added sugar content, it can help prevent cavities by keeping certain oral bacteria in check and stopping plaque from forming on teeth.

A 2009 studyTrusted Source showed that polyphenols in cocoa, as well as certain ones in coffee and tea, successfully kill cavity-causing bacteria and create a barrier between teeth and plaque.

In 2019, researchers found that a cocoa bean mouth rinse destroyed S. mutansTrusted Source bacteria — those most responsible for cavities — equally well to a prescription mouthwash. Even better, there wasn’t evidence that it blasted away other beneficial bacteria in the oral microbiome.

Stick to cacao nibs or dark chocolate with very little to no sugar, as the extra stuff in your average Snickers bar will totally counteract the benefits of the chocolate.

2. Grass-fed dairy

Grass-fed dairy products are high in vitamin K2, which is important for healthy teeth. Getty Images

Grass-fed dairy products, such as cheese and butter, are high in vitamin K2, a nutrient that is vital for healthy teeth. However, a majority of the world’s population is probably vitamin K2 deficientTrusted Source.

While all other mammals can efficiently convert vitamin K1 to K2 in the digestive system, humans don’t have the proper enzyme to make it happen.

And don’t minimize the importance of grass-fed. The enzyme other mammals have is activated by chlorophyll, so animals that live on grain and corn are probably not going to provide a vitamin K2-rich product.

Other high K2 foods that support dental health include natto, beef, goose liver pâté, eggs, and chicken liver. Bonus: Many of these foods are also high in phosphorus, a nutrient that teeth crave.

3. Fatty fish

Fatty fish is high in vitamin D, which can help reduce the risk of tooth decay. Getty Images

Fatty fish is an important component of many healthy diet patterns, as it’s so high in vitamin D. This nutrient is necessary for nearly every system of the body, but one of its lesser-known benefits is its ability to reduce the riskTrusted Source of tooth decay.

Vitamin D works synergistically with vitamins A and K2 to deliver calcium to the teeth, strengthening enamel from the inside out. A deficiency in any of these nutrients can lead to weakened enamel.

Oily fish are also high in omega-3s. Omega-3 fats support gum health and may even help prevent and reduceTrusted Source symptoms of periodontitis (gum disease), which affects nearly half of adults in the United States.

In other words, if your gums regularly bleed when brushing or flossing, consider upping your omega-3 intake to reduce inflammation and bleeding.

Tuna, mackerel, salmon, and trout are some of the fish highest in both vitamin D and omega-3s.

4. Leafy greens

Leafy greens help the mouth produce more nitrate- and nitrite-reducing bacteria. Getty Images

Greens are beneficial prebiotics within the mouth that healthy oral bacteria feed on. In contrast to high carbohydrate foods, leafy greens help the mouth produce more nitrite-reducing bacteria. In turn, your mouth and cardiovascular system benefit from an increaseTrusted Source in nitric oxide.

Not only will leafy greens leave your teeth feeling cleaner, but they’ll also actively support a healthier oral microbiome.

Darker leafy greens are best for teeth, as they’re also high in minerals your teeth uptake during remineralization to strengthen their structure. Good examples of these include kale, spinach, turnip greens, Swiss chard, and arugula.

5. Grapefruit and oranges

Both grapefruit and oranges contain high levels of vitamin C, which strengthens the blood vessels and connective tissues within the mouth. Getty Images

While acidic foods can have a negative effect on teeth, grapefruit, oranges, and other citrus fruits can actually benefit oral health when eaten in moderation.

Both grapefruit and oranges contain high levels of vitamin C, which strengthens the blood vessels and connective tissues within the mouth. It slows the progression of gum inflammation that could otherwise lead to gum disease.

A 2005 studyTrusted Source found that after just 2 weeks of daily grapefruit consumption, participants had improved their vitamin C levels and reduced bleeding gums.

Foods to avoid

1. Crackers

Carbohydrates in crackers break down quickly in the mouth and, within seconds, are just sugar for pathogenic bacteria to feast on. Getty Images

Patients have been surprised for years when I tell them that crackers, not candy, are probably the most dangerous foods for oral health.

The carbohydrates in crackers like saltines or Goldfish break down quickly in the mouth and, within seconds, are just sugar for pathogenic bacteria to feast on. As the bacteria chow down, they excrete acid onto teeth that can lead to plaque buildup and tooth decay.

Craving crackers but want to protect your teeth? Try a brand made from just seed and nuts but no wheat.

2. Dried fruit

Dry fruit is stripped of its water, leaving behind a substance that feeds sugar directly to your oral microbiome. Getty Images

The term “fruit” makes it sound healthy, but dried fruit has been stripped of all water. What’s left behind is similar to a sticky caramel that feeds sugar to the oral microbiome.

Combine this with the low pH of many fruits, and you’re left with a sneaky culprit behind cavities.

Whole fruit is far more beneficial to oral health, in part because of the water it contains.

3. Soda (yes, even diet soda)

In addition to their high sugar content, many sodas are also highly acidic. Getty Images

Apart from their high sugar content, all sodas — even the ones with zero calories — contain a great deal of acid. On the pH scale, many common soft drinks rank between 2 and 3, which is highly acidic even compared with drinks such as coffee.

Acidity to this level within the mouth is more than likely going to contribute to decay, gum inflammation, and a general dysbiosis of the oral microbiome.

If you want to indulge with soda but protect your teeth, drink it over a short period of time — don’t sip for hours on end — and swish with water immediately after to provide a buffer for your teeth. Wait about 45 minutes, then brush your teeth.

4. Kombucha

Many brands of kombucha contain a significant amount of added sugar and don’t actually contain active bacteria that help the body fight disease. Getty Images

Kombucha is generally considered a healthy drink because it contains healthy bacteria and many antioxidants that help the body fight disease.

However, many brands of kombucha contain a significant amount of added sugar and don’t actually contain active bacteria. In this case, the benefits may outweigh the drawbacks.

To get a kombucha that is good for your oral and gut health, look for one that has visible particles — leftover from the SCOBY used to brew it — and no added sugars.

After finishing a serving, rinse your mouth with water, then brush 45 minutes later to prevent acid attacks from opportunistic, sugar-loving bacteria.

5. Beans and lentils

Phytic acid in beans and lentils binds to nutrients such as calcium, phosphorus, vitamin D, and magnesium and may make it more difficult for your teeth to absorb them. Getty Images

Beans and lentils are foods often considered healthy — for good reason — but the presence of phytic acid might mean that they contribute to tooth decay.

Phytic acid binds to nutrients such as calcium, phosphorus, vitamin D, and magnesium and may make it more difficult for your teeth to absorb them.

Deficiencies of nutrients like these can make you more susceptible to cavities and periodontitis.

The good news is that beans and lentils, when stripped of excess phytic acid, actually promote good health.

To eliminate phytic acid, consider soaking your beans, lentils, and other grains overnight before eating them. You can also buy sprouted grains, which means their phytic acid content has already been reduced.

Mark Burhenne, DDS, is the co-founder of AsktheDentist.com and the #1 bestselling author of The 8-Hour Sleep Paradox. He’s on a mission to empower people everywhere with the same evidence-based, easy-to-understand dental health advice his patients get.

Face Masks Critical In Preventing Spread of COVID-19

A study by a team of researchers led by a Texas A&M University professor has found that not wearing a face mask dramatically increases a person’s chances of being infected by the COVID-19 virus.

Renyi Zhang, Texas A&M Distinguished Professor of Atmospheric Sciences and the Harold J. Haynes Chair in the College of Geosciences, and colleagues from the University of Texas, the University of California-San Diego and the California Institute of Technology have had their work published in the current issue of PNAS (Proceedings of the National Academy of Sciences).

The team examined the chances of COVID-19 infection and how the virus is easily passed from person to person. From trends and mitigation procedures in China, Italy and New York City, the researchers found that using a face mask reduced the number of infections by more than 78,000 in Italy from April 6-May 9 and by over 66,000 in New York City from April 17-May 9.

“Our results clearly show that airborne transmission via respiratory aerosols represents the dominant route for the spread of COVID-19,” Zhang said. “By analyzing the pandemic trends without face-covering using the statistical method and by projecting the trend, we calculated that over 66,000 infections were prevented by using a face mask in little over a month in New York City. We conclude that wearing a face mask in public corresponds to the most effective means to prevent inter-human transmission.

“This inexpensive practice, in conjunction with social distancing and other procedures, is the most likely opportunity to stop the COVID-19 pandemic. Our work also highlights that sound science is essential in decision-making for the current and future public health pandemics.”

One of the paper’s co-authors, Mario Molina, is a professor at the University of California-San Diego and a co-recipient of the 1995 Nobel Prize in Chemistry for his role in understanding the threat to the Earth’s ozone layer of human-made halocarbon gases.

“Our study establishes very clearly that using a face mask is not only useful to prevent infected coughing droplets from reaching uninfected persons, but is also crucial for these uninfected persons to avoid breathing the minute atmospheric particles (aerosols) that infected people emit when talking and that can remain in the atmosphere tens of minutes and can travel tens of feet,” Molina said.

Zhang said that many people in China have worn face masks for years, mainly because of the bad air quality of the country.

“So people there are sort of used to this,” he said. “Mandated face-covering helped China in containing the COVID-19 outbreak.”

Zhang said the results should send a clear message to people worldwide — wearing a face mask is essential in fighting the virus.

“Our work suggests that the failure in containing the propagation of COVID-19 pandemic worldwide is largely attributed to the unrecognized importance of airborne virus transmission,” he said. “Social-distancing and washing our hands must continue, but that’s not sufficient enough protection. Wearing a face mask as well as practicing good hand hygiene and social distancing will greatly reduce the chances of anyone contracting the COVID-19 virus.”

The study was funded by the Robert A. Welch Foundation.

COVID-19 Replicating RNA Vaccine Has Robust Response In Nonhuman Primates

A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion that goes by the acronym LION, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. These antibodies potently neutralize the virus.

The effects occurred within two weeks after administration through injection into a muscle. The level of antibodies generated was comparable to those in people who are recovering from COVID-19.

The vaccine induced coronavirus-neutralizing antibodies robustly in both younger and older mice. This hopeful finding was well-received by the researchers, because of the concern that the elderly are less likely to respond to vaccination due to their aging immune systems.

Vulnerability to severe COVID-19 in older people increases with age; a vaccination suitable for this high-risk population is a key goal of the scientists.

This vaccine design, as shown in lab studies, is designed to avoid immune responses that could enhance a respiratory disease induced by the coronavirus. Instead, it directs the immune response toward more protective antiviral measures. In addition to antibody production that can block the infection, the vaccine induces T cells, a type of white blood cell that provides a second line of defense if antibodies don’t completely block the infection.

The methods and results of animal tests of the replicating RNA coronavirus vaccine candidate vaccine are published July 20 in Science Translational Medicine.

The lead author of the paper is Jesse H. Erasmus, a Washington Research Foundation Postdoctoral Fellow in the laboratory of Deborah Heydenberg Fuller. She is a professor of microbiology at the University of Washington School of Medicine and division chief of Infectious Diseases and Translational Medicine at the Washington National Primate Research Center.

As COVID-19 continues to spread, the discovery and widespread distribution of safe and effective vaccines are essential for slamming down the pandemic. Scores of vaccine candidates are in various stages of testing around the world, from preclinical studies to human trials.

“A vaccine that can stop COVID-19,” Fuller wrote, “will ideally induce protective immunity after only a single immunization, avoid immune responses that could exacerbate virus-induced pathology, be amenable to rapid and cost-effective scale-up and manufacturing, and be capable of inducing immunity in all populations including the elderly who typically respond poorly to vaccines.”

“That’s a tall order,” she added. She sees conventional nucleic acid vaccines as promising, but at least two immunizations are needed to instill immunity in people.

Most DNA vaccines require high doses to achieve protective levels of immunity in humans. Traditional messenger RNA vaccines formulated with lipid nanoparticles to increase their effectiveness may face obstacles of mass-production and shelf life.

To try to overcome these limitations, the labs of Fuller and her collaborators at the National Institutes of Health Rocky Mountain Laboratories and HDT Bio Corp. have developed a replicating RNA version of a coronavirus vaccine.

Replicating RNA vaccines for other infectious diseases and cancers are in the pipeline at several institutions.

Replicating RNA expresses a greater amount of protein, and also triggers a virus-sensing stress response that encourages other immune activation.

In the case of the COVID-19 vaccine candidate, the RNA enters cells and instructs them to produce proteins that teach the body to recognize coronaviruses and attack them with antibodies and T cells.

This blockade might keep the viruses from fusing to cells and injecting their genetic code for commandeering cellular activities.

These antibodies induced by the vaccine provide protection by interfering with the protein machinery on the spikes of the coronavirus.

This replicating RNA vaccine contains the novel Lipid InOrganic Nanoparticle (LION) developed by Seattle-based biotechnology company HDT Bio Corp.

“We are pleased with the collaboration with UW to move our RNA vaccine platform forward,” said the company’s CEO, Steve Reed.

Amit P. Khandhar, the lead formulation developer, added, “RNA molecules are highly susceptible to degradation by enzymes. LION is a next-generation nanoparticle formulation that protects the RNA molecule and enables in vivo delivery of the vaccine after a simple mixing step at the pharmacy.”

The nanoparticle enhances the vaccine’s ability to provoke the desired immune reaction, and also its stability. This vaccine is stable at room temperature for at least one week. Its components would allow it to be rapidly manufactured in large quantities, should it prove safe and effective in human trials.

The scientists anticipate that lower and fewer doses would need to be made to immunize a population.

A key differentiating factor between LION and the lipid nanoparticle delivery vehicle used in other mRNA COVID-19 vaccines is its ability to be formulated with mRNA by simple mixing at the bedside.

The two-vial approach enabled by LION allows for manufacturing of the formulation independently from the mRNA component.

The research team is working to advance the vaccine to Phase 1 testing in people, in which it would be introduced into a small group of healthy volunteers to gather preliminary data on whether it is safe and generates the desired immune response.

HDT is advancing the replicon RNA with LION vaccine toward clinical development under the name HDT-301.

Experimental COVID-19 Vaccine Safe, Generates Immune Response

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in the New England Journal of Medicine.

The ongoing Phase 1 trial is supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The experimental vaccine is being co-developed by researchers at NIAID and at Moderna, Inc. of Cambridge, Massachusetts. Manufactured by Moderna, mRNA-1273 is designed to induce neutralizing antibodies directed at a portion of the coronavirus “spike” protein, which the virus uses to bind to and enter human cells.

The trial was led by Lisa A. Jackson, M.D., MPH, of Kaiser Permanente Washington Health Research Institute in Seattle, where the first participant received the candidate vaccine on March 16. This interim report details the initial findings from the first 45 participants ages 18 to 55 years enrolled at the study sites in Seattle and at Emory University in Atlanta. Three groups of 15 participants received two intramuscular injections, 28 days apart, of either 25, 100 or 250 micrograms (mcg) of the investigational vaccine. All the participants received one injection; 42 received both scheduled injections.

In April, the trial was expanded to enroll adults older than age 55 years; it now has 120 participants. However, the newly published results cover the 18 to 55-year age group only.

Regarding safety, no serious adverse events were reported. More than half of the participants reported fatigue, headache, chills, myalgia or pain at the injection site. Systemic adverse events were more common following the second vaccination and in those who received the highest vaccine dose. Data on side effects and immune responses at various vaccine dosages informed the doses used or planned for use in the Phase 2 and 3 clinical trials of the investigational vaccine.

The interim analysis includes results of tests measuring levels of vaccine-induced neutralizing activity through day 43 after the second injection. Two doses of vaccine prompted high levels of neutralizing antibody activity that were above the average values seen in convalescent sera obtained from persons with confirmed COVID-19 disease.

A Phase 2 clinical trial of mRNA-1273, sponsored by Moderna, began enrollment in late May. Plans are underway to launch a Phase 3 efficacy trial in July 2020.

Additional information about the Phase 1 clinical trial design is available at ClinicalTrials.gov using the identifier NCT04283461. This trial was supported in part by the NIAID grants UM1AI148373 (Kaiser Permanente Washington), UM1AI148576 (Emory University) and UM1AI148684 (Infectious Diseases Clinical Research Consortium). Funding for the manufacture of mRNA-1273 Phase 1 material was provided by the Coalition for Epidemic Preparedness Innovations (CEPI).

Follow by Email
LinkedIn
Instagram
WhatsApp